Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CRM
|
John Victor Roos
Director |
SELL
Open market or private sale
|
Direct | 119 Reduced 1.49% |
$22,571
$189.67 p/Share
|
Jun 19
2020 |
|
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 11,046 Reduced 1.0% |
$718,432
$65.04 p/Share
|
Jun 19
2020 |
|
AGHC
|
Ibex Investors LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 7,500 Reduced 1.95% |
$525
$0.07 p/Share
|
Jun 19
2020 |
|
AXS
|
Charles A Davis
Director |
BUY
Open market or private purchase
|
Indirect | 200,000 Added 7.62% |
$8,646,000
$43.23 p/Share
|
Jun 19
2020 |
|
GRTX
|
Novartis Bioventures LTD |
SELL
Open market or private sale
|
Direct | 1,001,312 Reduced 28.86% |
$8,260,824
$8.25 p/Share
|
Jun 19
2020 |
|
COST
|
Roland Michael Vachris
President and CEO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 24.56% |
$1,203,800
$300.95 p/Share
|
Jun 19
2020 |
|
CNA
|
Loews Corp
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 25,784 Added 0.01% |
$835,659
$32.41 p/Share
|
Jun 19
2020 |
|
ARES
|
Antony P Ressler
Co-Founder & Exec. Chairman |
SELL
Open market or private sale
|
Indirect | 132,213 Reduced 7.78% |
$5,178,783
$39.17 p/Share
|
Jun 19
2020 |
|
AUB
|
Michael W Clarke |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 0.4% |
$47,500
$23.75 p/Share
|
Jun 19
2020 |
|
PRTS
|
David Kanen
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 277,755 Reduced 9.58% |
$2,419,246
$8.71 p/Share
|
Jun 19
2020 |
|
ACTG
|
Marc W. Booth
Chief IP Officer |
BUY
Grant, award, or other acquisition
|
Direct | 100,000 Added 32.66% |
-
|
Jun 18
2020 |
|
NROM
|
William Wildman
Director |
BUY
Open market or private purchase
|
Direct | 3,000 Added 50.0% |
$1,020
$0.34 p/Share
|
Jun 18
2020 |
|
EBTC
|
Stephen J Irish
EVP - Principal Subsidiary |
SELL
Bona fide gift
|
Indirect | 325 Reduced 0.88% |
-
|
Jun 18
2020 |
|
NVNO
|
Biodyne Holding, S.A. |
SELL
Open market or private sale
|
Direct | 61,640 Reduced 2.2% |
$27,738
$0.45 p/Share
|
Jun 18
2020 |
|
IMMU
|
Behzad Aghazadeh
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,718 Added 17.75% |
-
|
Jun 18
2020 |
|
AVID
|
Christian Asmar
Director |
BUY
Open market or private purchase
|
Indirect | 10,375 Added 0.15% |
$72,418
$6.98 p/Share
|
Jun 18
2020 |
|
RPRX
|
Adage Capital Partners Gp, L.L.C.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,000,000 Added 6.12% |
$84,000,000
$28.0 p/Share
|
Jun 18
2020 |
|
RPRX
|
Adage Capital Partners Gp, L.L.C.
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 43,015,330 Added 50.0% |
-
|
Jun 18
2020 |
|
DAL
|
Francis S Blake
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,910 Added 13.55% |
-
|
Jun 18
2020 |
|
DAL
|
Ashton B Carter
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,690 Added 26.61% |
-
|
Jun 18
2020 |
|
DAL
|
David G Dewalt
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,690 Added 8.61% |
-
|
Jun 18
2020 |
|
DAL
|
William H Easter Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,690 Added 31.11% |
-
|
Jun 18
2020 |
|
DAL
|
Michael P Huerta
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,690 Added 26.83% |
-
|
Jun 18
2020 |
|
DAL
|
Jeanne P Jackson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,690 Added 23.24% |
-
|
Jun 18
2020 |
|
DAL
|
George N Mattson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,690 Added 6.35% |
-
|
Jun 18
2020 |
|
DAL
|
Sergio Rial
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 939 Reduced 4.41% |
$28,912
$30.79 p/Share
|
Jun 18
2020 |
|
DAL
|
Sergio Rial
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,690 Added 21.09% |
-
|
Jun 18
2020 |
|
DAL
|
David S Taylor
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,690 Added 25.47% |
-
|
Jun 18
2020 |
|
DAL
|
Kathy N Waller
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,690 Added 19.81% |
-
|
Jun 18
2020 |
|
CNO
|
John R Kline
SVP and CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 21 Reduced 0.02% |
$326
$15.5 p/Share
|
Jun 18
2020 |
|
CNO
|
John R Kline
SVP and CAO |
BUY
Grant, award, or other acquisition
|
Direct | 700 Added 0.81% |
$10,850
$15.5 p/Share
|
Jun 18
2020 |
|
AGHC
|
Ibex Investors LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 263,889 Reduced 17.85% |
$15,833
$0.06 p/Share
|
Jun 18
2020 |
|
AXS
|
Charles A Davis
Director |
BUY
Open market or private purchase
|
Indirect | 375,000 Added 8.09% |
$15,862,500
$42.3 p/Share
|
Jun 18
2020 |
|
AXS
|
Thomas C. Ramey
Director |
SELL
Open market or private sale
|
Direct | 2,190 Reduced 13.88% |
$91,301
$41.69 p/Share
|
Jun 18
2020 |
|
ZM
|
Kelly Steckelberg
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 11,066 Reduced 39.42% |
$2,669,341
$241.22 p/Share
|
Jun 18
2020 |
|
ZM
|
Kelly Steckelberg
Chief Financial Officer |
BUY
Conversion of derivative security
|
Indirect | 5,982 Added 32.45% |
-
|
Jun 18
2020 |
|
GRTX
|
Novartis Bioventures LTD |
SELL
Open market or private sale
|
Direct | 900 Reduced 0.03% |
$8,136
$9.04 p/Share
|
Jun 18
2020 |
|
RILY
|
Randall E Paulson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,456 Added 20.57% |
-
|
Jun 18
2020 |
|
RILY
|
Michael Joseph Sheldon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,456 Added 13.81% |
-
|
Jun 18
2020 |
|
RILY
|
Marian Walters
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,456 Added 37.74% |
-
|
Jun 18
2020 |
|
RILY
|
Mikel H Williams
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,456 Added 5.12% |
-
|
Jun 18
2020 |
|
RILY
|
Agostino Robert P D
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,456 Added 2.43% |
-
|
Jun 18
2020 |
|
RILY
|
Robert L Antin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,456 Added 21.09% |
-
|
Jun 18
2020 |
|
RILY
|
Todd D. Sims
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,456 Added 16.32% |
-
|
Jun 18
2020 |
|
RPRX
|
Legorreta Pablo G.
CEO, Chairman of the Board |
BUY
Conversion of derivative security
|
Indirect | 241,810 Added 50.0% |
-
|
Jun 18
2020 |
|
RPRX
|
Legorreta Pablo G.
CEO, Chairman of the Board |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 50.0% |
$560,000
$28.0 p/Share
|
Jun 18
2020 |
|
SREV
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 250,000 Added 2.27% |
$380,000
$1.52 p/Share
|
Jun 18
2020 |
|
CNA
|
Loews Corp
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 73,583 Added 0.03% |
$2,423,824
$32.94 p/Share
|
Jun 18
2020 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 236 Added 0.08% |
$145,116
$614.9 p/Share
|
Jun 18
2020 |
|
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 53,770 Reduced 0.05% |
$8,704,288
$161.88 p/Share
|
Jun 18
2020 |